Turcot syndrome is characterized by an association of malignant brain tumors and colon cancer developing in the patient's teens. Since the mechanism of carcinogenesis in Turcot syndrome is still unclear, we analysed genetic changes in tumors from a Turcot patient with no family history of the condition. All tumors, including one astrocytoma, three colon carcinomas, and two colon adenomas, exhibited severe replication error (RER), and all colon tumors showed somatic muations at repeated regions of TGFbRII, E2F-4, hMSH3, and/or hMSH6 genes. Somatic APC mutations were detected in three of three colon carcinomas, and somatic p53 mutations were detected in the astrocytoma and two of three colon carcinomas, both of which showed two mutations without allele loss. We also found that normal colon mucosa, normal skin ®broblasts and normal brain tissue from this patient showed respective high frequencies of RER, in contrast to usual HNPCC patients in which RER was very rare in normal tissues. These results suggest that extreme DNA instability in normal tissues causes the early development of multiple cancer in Turcot syndrome. A missense mutation (GAG to AAG) at codon 705 of hPMS2 gene was detected in one allele of this patient, which was inherited from his mother without tumors. Additional unknown germline mutation may contribute to the genetic instability in normal tissues.
Keywords: Turcot syndrome; genetic instability; colon tumor; brain tumor; RER in normal tissue Turcot syndrome is characterized by an association of malignant tumors of central nervous system and colon tumors. It has been suggested that there are three types of Turcot syndrome (Turcot et al., 1959; Itoh and Ohsato, 1985) : an autosomal dominant type associated with familial adenomatous polyposis (FAP), an autosomal dominant type associated with hereditary nonpolyposis colorectal cancer (HNPCC), and a recessively inherited type. Although about 10 dominantly inherited cases with germline mutation of APC gene Hamilton et al., 1995) and two dominant cases with germline mutation of DNA mismatch repair genes , have been reported as Turcot, the causative gene of recessive cases has not been identi®ed, and the mechanism of carcinogenesis in every type of Turcot syndrome is still unclear.
The present case of Turcot had no family history of tumors of any kind in his parents. This patient developed a grade IV astrocytoma at the age of 7, which recurred at 9, a malignant lymphoma at 15, a ®broma at 15, three independent colon adenocarcinomas and nearly 10 colonic polyps in the period between the ages of 13 and 16. The patient, who had suered from slight mental retardation, died at 16. We analysed genetic changes in six tumors, including one astrocytoma (As, at age 9), two carcinomas of the sigmoid colon (CoCa1, which occurred at age 13, and CoCa2, at 15), one carcinoma of the ascending colon (CoCa3, at 16), and two tubular adenomas of the colon (CoAd1, at 13, and CoAd3, at 15).
To examine whether the patient was FAP with new APC germline mutation, DNA samples from tumors and normal tissue of the same patient were thoroughly analysed for mutation in the entire coding sequence of the APC gene; however germline mutation was not detected. We then examined the possibility that this patient may have been a kind of HNPCC. Microsatellite alteration, which is the characteristic of HNPCC tumors , was checked for in six tumors at ®ve regions. All six tumors exhibited obvious alteration at three or more regions, as shown in Figure 1a and Table 1 . Moreover, all of the colon adenomas and carcinomas also showed insertion or deletion mutations at (A) 10 region of TGFbRII gene (Marcowitz et al., 1995) , four of these tumors additionally showed alterations at (A) 8 region of hMSH3 and/or (C) 8 region of hMSH6 genes (Malkhosyan et al., 1996) , and two of three carcinomas had alterations at (AGC) 13 region of E2F-4 gene (Yoshitaka et al., 1996) . These alterations are characteristics similar to those observed in HNPCC tumors with RER(+). However, mutation at (G) 8 region of Bax gene (Rampino et al., 1997) , which occurred in 50% of usual HNPCC colorectal carcinomas (unpublished data), was not detected in these Turcot carcinomas.
We conducted further tests to see if somatic mutation of APC, p53, and K-ras genes occurred in these Turcot tumors at a high frequency as in non-HNPCC (Miyaki et al., 1994) , or at low frequencies, as in usual HNPCC (Konishi et al., 1996) . All three colon carcinomas showed somatic mutations of APC gene. These mutations were a nonsense mutation at codon 1450 (CGA to TGA), an A insertion at codon 847 ± 848 (GAAAAAG to GAAAAAAG), an A insertion at codon 1554 ± 1556 (GAAAAAAC to GAAAAAAAC), an AG insertion at codon 1462 ± 1465 (AGAGAGA-GAG to AGAGAGAGAGAG), and three missense mutations, as indicated in Table 1 . These mutations could have possibly resulted from very severe replication error, although two of them were the same as those detected in intestinal tumors from FAP and sporadic cases. With respect to p53 gene, the
As Normal Microsatellite instability in diluted DNA of normal mucosa from a Turcot patient, and that of normal mucosae from two HNPCC patients with germline mutation of hMSH2 (codon 811, TTA to TGA) or hMLH1 (codon 616-618, AGG del.). Diluted DNA of normal mucosa was ampli®ed by PCR reaction of 35 cycles, containing DNA, primers for the microsatellite marker D2S123, and [ 32 P]dCTP, in 96-well system. Other PCR conditions were those described previously (Konishi et al., 1996) . Products from 13 to 16 parallel PCR reactions were simultaneously electrophoresed through 6% polyacrylamide gel containing 7 M urea. The amount of DNA was 3 ± 30 pg in each PCR reaction. Each lane corresponds to each PCR reaction. Arrows indicate the positions of normal alleles which were the same as those in the PCR products from undiluted DNA samples. Some PCR reactions of diluted DNA contained none or only one band, although PCR reaction of undiluted DNA always showed two normal bands. PCR products with abnormal mobilities were present in 4, 5, 6, 7, 8, 11, 15th and 16th lanes of the PCR products (from the left) in the case of Turcot patient, but the abnormal bands were not detected in 13 PCR reaction products in the case of HNPCC patient with hMSH2 germline mutation, nor in 16 PCR reactions in the case of HNPCC patient with hMLH1 germline mutation Primers and conditions for PCR, SSCP and direct sequencing in mutation analyses were those previously reported: hMSH3 and hMSH6 (Malkosyan et al., 1996) ; TGFbRII (Konishi et al., 1996) ; BAX (Rampino et al., 1997) ; E2F-4 (Yoshitaka et al., 1996) ; APC (Groden et al., 1991) . K-ras gene mutation was detected at codon 13 (GGC to GAC) in one of colon tumors (CoCa1). Such a high frequency of APC and p53 gene mutation has not previously been observed in our HNPCC carcinomas with germline mutation of hMSH2 or hMLH1 gene (Konishi et al., 1996) . A p53 mutation and a K-ras mutation have also been detected in a colorectal carcinoma from a Turcot patient, but other genetic changes have not been described (Rochlitz et al., 1993) . In order to examine why this patient developed multiple tumors in the colon and other tissues at an early age and why these tumors had such drastic genetic alterations, we analysed replication error in normal tissues from this patient, and compared it to that in normal tissues from HNPCC patients with already identi®ed germline mutation in hMSH2 or hMLH1 gene (Miyaki et al., 1995) . So as to analyse the DNA in individual cells of normal tissue, DNA solutions were diluted to such a concentration that some fractions exhibited absence of band or one band corresponding to one allele in PCR reactions, as described previously . Products of 16 to 64 parallel PCR reactions, containing primers for each microsatellite marker and each diluted DNA sample from normal tissues of Turcot, HNPCC, FAP and sporadic patients, were electrophoresed through polyacrylamide gel. The percentages of cells with microsatellite alterations were expressed as the number of PCR reactions exhibiting abnormal bands divided by the number of PCR reactions exhibiting visible bands (normal or abnormal) in electrophoresis.
As indicated in Figure 1b and Table 2 , DNA from normal colon mucosa (at age of 15) of this patient, analysed at a low concentration, showed a high frequency (53%) of DNA instability, compared with the absence of such high instability in known HNPCC patients. Cultured normal skin ®broblasts (at age 15) and normal brain tissue (at age 9) of this patient also showed the instability (23% and 22%, respectively). This instability was not the result of contaminated cancer cells, because the normal mucosa was obtained from a region remote from the site of the carcinoma (CoCa2) and the heterogeneous pattern of abnormal bands in individual PCR reactions in normal mucosa was dierent from that of CoCa2. Furthermore, no mutant band for A 10 region of TGFbRII gene was detected in the preparation of normal mucosa. As indicated in Table 2 , lymphocytes from both of the patient's parents and known HNPCC patients did not show high instability. High DNA instability in normal tissue has recently been reported in cases of knock-out mice with homologous mutation of PMS2 or MSH2 gene (Baker et al., 1995; de Wind et al., 1995; Narayanan et al., 1997) , and in cases of HNPCC patients with a germline mutation of hPMS2 gene, which patients developed colorectal cancer in their teens , but whether these HNPCC cases were Turcot or not has not been clari®ed.
In the present patient and his parents, germline mutation in mismatch repair genes (Fishel et al., 1993; Leach et al., 1993; Bronner et al., 1994; Nicolaides et al., 1994 Nicolaides et al., , 1995 Papadopoulos et al., 1994; Palombo et , 1995) was analysed using PCR ± SSCP, RT ± PCR ± SSCP, direct sequencing, and/or IVSP (in vitro synthesized protein) methods. However, no germline mutation was detected in coding regions of hMSH2, hMLH1, hPMS1, hPMS2, hMSH6, and JTV1 genes (in the patient and the parents), with the exception of a germline mutation of GAG(Glu) to AAG(Lys) at codon 705 of hPMS2 gene inherited from his mother, which may not be polymorphism as it has not been detected in 80 other individuals. One somatic mutation at the promoter region of hPMS2 gene (a C deletion at nt7123*7120 upstream of the codon 1) was detected in one colon carcinoma (CoCa2). However, the eects of these germline and somatic alterations in hPMS2 gene are unclear as yet. This germline mutation of hPMS2 alone may not be the cause of Turcot syndrome, because his mother had no tumors, and her normal lymphocytes did not show the same DNA instability seen in her son. This Turcot patient may be a unique case to the usual HNPCC patient, as follows: (a) although our previous examination has shown that colorectal carcinomas from HNPCC patients with germline mutation of hMSH2 or hMLH1 gene exhibited very low frequencies of somatic mutations in APC and p53 genes, all three colon carcinomas from this Turcot patient exhibited somatic APC mutations, and two of three colon carcinomas had p53 mutations; (b) normal tissues of this Turcot syndrome patient showed high DNA instability, whereas that of known HNPCC patients exhibited no such instability; (c) in usual HNPCC cases, colorectal tumors develop later in life, such as after age 40, compared to Turcot syndrome, such as 7 ± 13 years old in the present case.
The high DNA instability in our case of Turcot syndrome suggests that the patient was a homozygote of a recessive mutation of a gene, including the possibility of hPMS2. Alternatively, this patient may be a compound heterozygote for mutations in the hPMS2 or other unknown mismatch repair gene bearing a high frequency of replication error in normal tissues, in contrast to the hetrozygotes for mutation of hMSH2 or hMLH1 gene. In either case, it may be that the RER(+) phenotype causes replication errors rapidly and simultaneously in other mismatch repair genes and cancer-related genes. This severe genetic instability may result in the very early development of malignant brain tumors, colorectal tumors, malignant lymphoma, and ®bromas, as in the cases of homologously de®cient mice with respect to PMS2 or MSH2 (Baker et al., 1995; de Wind et al., 1995) . Further studies are necessary to clarify the germline mutation of this patient and to detect genetic alterations in carcinomas from other Turcot patients, to fully understand the mechanisms of carcinogenesis in this syndrome. 
